Lonza News Feb 4, 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News Feb 3, 2026 Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail
Lonza News Feb 3, 2026 45% earnings growth over 1 year has not materialized into gains for Lonza Group (VTX:LONN) shareholders over that period - Yahoo Finance
Lonza News Feb 3, 2026 Earnings call transcript: Lonza misses Q4 2025 forecasts, stock drops 9% - Investing.com
Lonza News Feb 2, 2026 Lonza Group AG: The Silent Engine Powering the Next Wave of Biotech - AD HOC NEWS
Lonza News Jan 30, 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN
Lonza News Jan 30, 2026 CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine
Lonza News Jan 29, 2026 Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
Lonza News Jan 29, 2026 'We don't stop': How a new owner is turning around a former Genentech site - The Business Journals
Lonza News Jan 29, 2026 Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
Lonza News Jan 29, 2026 Switzerland’s Lonza edges closer to sale of its capsule and health ingredients business - 93.3 The Drive
Lonza News Jan 28, 2026 Lonza still intends to sell its capsules and health ingredients business - Endpoints News